AROA BIOSURGERY LIMITED — Director's Dealing 2023

Mar 30, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Brian Ward
Date of last notice	27 July 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.		N/A
Date of change		31 March 2023
No. of securities held prior to change		IndirectMr Brian Ward & Mrs Tracey Ward <ArawaiNo 2 /C>33,125,800Fully Paid Ordinary Shares3,132,525Options exercisable at$0.75 expiring 23 July 2025
Class		1. Options exercisable at $Nil expiring 13November 2027(issued 28/11/22)2. Options exercisable at $1.165 expiringon 13 November 2027(issued 28/11/22)3. Options exercisable at $1.165 expiring29 February 20284. Options exercisable at $Nil expiring 29February 2028

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired		1. 1,217,6102. 649,6953. 254,9724. 453,206
Number disposed		-
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation		Nil
No. of securities held after change		IndirectMr Brian Ward & Mrs Tracey Ward <ArawaiNo 2 A/C>33,125,800Fully Paid Ordinary Shares3,132,525Options exercisable at$0.75 expiring 23 July 20251,217,610Options exercisable at $Nilexpiring 13 November 2027649,695Options exercisable at$1.165 expiring on 13November 2027254,972Options exercisable at$1.165 expiring 29February 2028453,206Options exercisable at $Nilexpiring 29 February 2028
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participationin buy-back		Issued on 31 March 2023 pursuant toshareholder approval received at the AnnualGeneral Meeting held on 10 August 2022

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder(if issued securities)	-
Date of change	-
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to which theinterest has changed	-
Interest acquired	-
Interest disposed	-
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation	-

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest after change -

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities orcontracts detailed above traded during a+closedperiodwherepriorwrittenclearance was required?	No
If so, was prior written clearance providedto allow the trade to proceed during thisperiod?	N/A
If prior written clearance was provided, onwhat date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3